Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients?

Background Sex differences for cardiovascular (CV) risk and outcomes in chronic kidney disease (CKD) patients not on dialysis have been scarcely or never investigated. We therefore studied this important aspect in a cohort of CKD stage 2–5 in the south of Italy. Methods We tested the relationship be...

Full description

Saved in:
Bibliographic Details
Published in:Clinical kidney journal 2023-11, Vol.16 (11), p.2141-2146
Main Authors: Provenzano, Pasquale Fabio, Caridi, Grazia, Parlongo, Giovanna, Leonardis, Daniela, Puntorieri, Elvira, Tripepi, Giovanni, Zoccali, Carmine, Mallamaci, Francesca
Format: Article
Language:English
Subjects:
Analysis
Chronic kidney failure
Mortality
Original
Patient outcomes
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Sex differences for cardiovascular (CV) risk and outcomes in chronic kidney disease (CKD) patients not on dialysis have been scarcely or never investigated. We therefore studied this important aspect in a cohort of CKD stage 2–5 in the south of Italy. Methods We tested the relationship between sex and fatal and non-fatal major CV events in a cohort of 759 stage 2–5 CKD patients followed up for a median time of 36 months. Results Out of 759 patients, 455 were males (60%) and the remaining 304 patients were females (40%). During the follow-up, 42 patients died, and 118 had fatal and non-fatal CV events. On univariate Cox regression analyses, the male sex failed to be associated with all-cause mortality but was strongly related to the incidence rate of fatal and non-fatal major CV events [hazard ratio (HR) 1.75, 95% confidence interval (CI) 1.18–2.60, P = .006]. Data adjustment for a series of major potential confounders did not materially affect the strength of this relationship (HR 1.78, 95% CI 1.03–3.09). Further analysis testing the effect of age on major CV outcomes by sex showed an effect modification by this risk factor on the same outcome (P = .037) because the HR of male versus female CV events increased progressively with aging. Conclusion Male patients in stage G2–5 CKD had a higher risk for CV events compared with female patients. Age was shown to be a risk modifier for the association between sex and CV events and this risk increased linearly across a wide age spectrum in CKD patients.
ISSN:2048-8505
2048-8513
DOI:10.1093/ckj/sfad174